2. 您的位置
3. 首页
4. 会议论文
5. LRG1 expression indicates unfavorable clinical outcome in hepatocellular carcinoma

LRG1 expression indicates unfavorable clinical outcome in hepatocellular carcinoma

来源 :第四届广州国际肿瘤学会议 | 被引量 : 0次 | 上传用户：aiyang1115

【摘 要】

：

　　Background: Leucine-rich-alpha-2-glycoprotein1(LRG1)is a novel oncogene-associated protein which has been clarified vital to the progression of human cancer

【作 者】

：

Chun-Hua Wang Min Li Li-Li Liu Jia Fu Chris Zhiyi Zhang Jing-Ping Yun 

【机 构】

：

Sun Yat-sen University Cancer Center

【出 处】

：

第四届广州国际肿瘤学会议

【发表日期】

：

2015年期

下载到本地 , 更方便阅读

下载此文 赞助VIP

声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架

论文部分内容阅读

　　Background: Leucine-rich-alpha-2-glycoprotein1(LRG1)is a novel oncogene-associated protein which has been clarified vital to the progression of human cancers,but its role in hepatocellular carcinoma(HCC)remains unclear.

其他文献

INFLUENCE ON MALIGNANT BIOLOGICAL BEHAVIORSOF GLIOMA CELL LINES THROUGH DOWN-REGULATION OF CANCER-TE

会议

The 4th guangzhou International symposium on oncology MiR-34b-3 and miR-449a inhibit malignant progr

　　Purpose: To investigate the tumor suppressing ability and mechanism of miR-34b/c cluster and miR-449a in nasopharyngeal carcinoma(NPC).

会议

EXPRESSION AND CLINICAL SIGNIFICANCES OF MAGE-D4,OY-TES-1 AND NY-SAR-35 IN GLIOMA

　　OBJECTIVE: To investigate the expression and clinical significances of tumor antigen MAGE-D 4,OY-TE S-1 and NY-SA R-35 in glioma and evaluate these three an

会议

The miR-24-Bim Pathway Regulates Tumor growth and Angiogenesis in Pancreatic Carcinoma

　　The conventional strategy for cancer therapy offers limited control of specificity and efficacy,study on the molecular mechanism involved in tumor growth an

会议

Cancer evolutionary modeling for precision medicine based therapeutics

会议

Pharmacological inactivation of AKT/ERK and β-Catenin by 7-difluoromethoxyl-5,4'-di-n-octyl gen

　　The epithelial-mesenchymal transition(EMT)has been shown to induce cancer stem traits.However,pharma-therapeutic approach to simultaneously prevent EMT and

会议

Randomized effects of five platinum-based chemotherapy regimens in the first treatment of advanced N

　　OBJECTIVE: To observe efficacy and security of five chemotherapeutic schemes including platinum on advanced nonsmall-cell lung cancer.

会议

Efficacy and security of treatment by bevacizumab and platinum-based on chemotherapy on advanced non

　　Objective: To evaluate efficacy and security of treatment by bevacizumab and platinum on advanced nonsmall-cell lung cancer.

会议

non small cell lung cancerandbevacizumabtreatmentsecurity

The mechanism of bevacizumab combined with cisplatin interfer the invasion and metastasis of lung ad

　　Objective: Research on the mechanism of bevacizumab combined with cisplatin inhibits the invasion and metastasis of Lewis lung adenocarcinoma.

会议

lung adenocarcinomainvasion and metastasisthecisplatinbevacizumab

Entinostat enhance the efficacy of cisplatin to inhibit esophageal squamous cell carcinoma

　　Esophageal squamous cell carcinoma is worse malignancy with high incidence and mortality for Chinese.

会议